Find a Research Expert

Experts
 Menu

John M Fitzpatrick

Institution

University College Dublin

Contact

Subjects

Biochemistry

Medicine & Nursing

Details
Publications 129
As first author 26
As last author 57
Unique topics 732
Collaborations 73
Sources 11
Are you John M Fitzpatrick? Click here to provide feedback on your profile.
All
2017
2016
2015
2014
2013
2012
2011
2010
2009
Earlier
All
2017
2016
2015
2014
2013
2012
2011
2010
2009
Earlier

2017

An evaluation of community-based cognitive stimulation therapy: a pilot study with an Irish population of people with dementia
2017

Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.
2017

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.
2016

Prepared for Practice? Interns' Experiences of Undergraduate Clinical Skills Training in Ireland.
2016

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.
2015

Guidelines for the definition of time to event endpoints in renal cell cancer clinical trials: results of the DATECAN project.
2014

Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.
2014

Prostate cancer risk assessment tools in an unscreened population.
2013

Expression of three Trichoderma reesei cellulase genes in Saccharomyces pastorianus for the development of a two-step process of hydrolysis and fermentation of cellulose.
2013

Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate Cancer.
2012

A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.
2012

Chairman's foreword. Recent advances in prostate cancer management.
2012

Management of castration-resistant prostate cancer: a call to urologists.
2012

Optimizing the management of prostate cancer in senior adults: call to action.
2011

Biomarker research in prostate cancer--towards utility, not futility.
2011

Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
2011

Epstein criteria for insignificant prostate cancer.
2011

Improved survival prospects for patients with castration-resistant prostate cancer.
2011

Maximizing outcomes in genitourinary cancers across the treatment continuum.
2011

The role of secreted frizzled-related protein 2 expression in prostate cancer.
2010

A gender comparison of postobstructive injury in the rat kidney.
2010

Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.
2010

Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.
2010

Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.
2010

The increasing incidence of mumps orchitis: a comprehensive review.
2009

Awareness of prostate cancer among patients and the general public: results of an international survey.
2009

Biomarkers in renal cell carcinoma.
2009

Carbonic anhydrase IX expression in prostate cancer.
2009

External validation of the 2007 and 2001 Partin tables in Irish prostate cancer patients.
2009

Hypoxia increases normal prostate epithelial cell resistance to receptor-mediated apoptosis via AKT activation.
2009

Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation.
2009

Prostate cancer: a serious disease suitable for prevention.
2009

Prostate-specific antigen kinetics in localized and advanced prostate cancer.
2008

Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines.
2008

Exploring mechanisms involved in renal tubular sensing of mechanical stretch following ureteric obstruction.
2008

Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
2008

Millin retropubic prostatectomy.
2008

Optimizing the management of prostate diseases: prostate cancer. Introduction.
2008

Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.
2008

Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
2008

The single insult of hypoxic preconditioning induces an antiapoptotic response in human proximal tubular cells, in vitro, across cold storage.
2008

Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder.
2007

Alpha-T-catenin (CTNNA3) displays tumour specific monoallelic expression in urothelial carcinoma of the bladder.
2007

Alterations in the expression of inhibitors of apoptosis during differentiation of prostate epithelial cells.
2007

Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney.
2007

Neonatal encephalopathy is associated with altered perinatal systemic neutrophil apoptosis.
2007

Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
2007

What is the role of inflammation in the pathogenesis of prostate cancer?
2006

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.
2006

Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines.
2006

Evidence-based medicine 'up front'.
2006

Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.
2006

Heat shock-induced protection of renal proximal tubular epithelial cells from cold storage and rewarming injury.
2006

Management of acute urinary retention.
2006

Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
2006

The natural history of benign prostatic hyperplasia.
2006

Urinary markers for prostate cancer.
2006

Which BPH treatment is the most clinically efficacious and cost-effective?
2005

Delayed graft function: a dilemma in renal transplantation.
2005

Handling the distal ureter during open nephroureterectomy: principles and techniques.
2005

Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells.
2005

Should combination therapy be standard for benign prostatic hyperplasia?
2005

Side-effects of treatments for locally advanced prostate cancer.
2005

Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins.
2004

An antisense oligonucleotide to cIAP-1 sensitizes prostate cancer cells to fas and TNFalpha mediated apoptosis.
2004

Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.
2004

Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins.
2004

Differentiation-induced HL-60 cell apoptosis: a mechanism independent of mitochondrial disruption?
2004

Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proteins during spontaneous and delayed apoptosis.
2004

Gene profiling of in vitro and in vivo models of delayed neutrophil apoptosis: a common pathway?
2004

Hypoxia inhibits human bladder smooth muscle cell proliferation: a potential mechanism of bladder dysfunction.
2004

Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease.
2004

Labor promotes neonatal neutrophil survival and lipopolysaccharide responsiveness.
2004

PSA measurement in the treatment of BPH.
2004

Phytoestrogens derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitro.
2004

Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies.
2003

Apoptosis in the prostate.
2003

DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.
2003

Endothelin in unilateral ureteral obstruction: vascular and cellular effects.
2003

Heat shock proteins in the genitourinary system.
2003

Human nucleus pulposis can respond to a pro-inflammatory stimulus.
2003

Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent.
2003

Pressure effects on cellular systems: is there a link with benign prostatic hyperplasia?
2003

Urinary tract involvement by colorectal cancer.
2002

Androgen-mediated resistance to apoptosis.
2002

Cytoprotective effects of nitrates in a cellular model of hydronephrosis.
2002

Effects of cyclic stretch on prostatic cells in culture.
2002

Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation.
2002

Inhibitors of apoptosis proteins in prostate cancer cell lines.
2002

Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators.
2002

The loss of IAP expression during HL-60 cell differentiation is caspase-independent.
2001

Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma.
2001

Insulin-like growth factor I and prostate cancer.
2001

Nitric oxide in unilateral ureteral obstruction: effect on regional renal blood flow.
2001

Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases.
2001

Sexual function in patients with benign prostatic hyperplasia.
2000

Altered caspase expression results in delayed neutrophil apoptosis in acute pancreatitis.
2000

Defining a role for the inhibitors of apoptosis proteins in prostate cancer.
2000

Glutathione depletion-induced neutrophil apoptosis is caspase 3 dependent.
2000

Heat-shock proteins inhibit induction of prostate cancer cell apoptosis.
2000

Insulin-like growth factor-1 alters apoptotic signalling in prostate cancer.
2000

Neutrophil apoptosis is delayed in patients with inflammatory bowel disease.
2000

New developments in the pharmacological management of prostate cancer.
2000

Signaling for the caspases: their role in prostate cell apoptosis.
2000

Target sites for manipulating apoptosis in prostate cancer.
2000

Thiol-mediated apoptosis in prostate carcinoma cells.
2000

Will laser replace TURP for the treatment of benign prostatic hyperplasia?
1999

Caspase protease manipulation: a novel approach to apoptotic induction in prostate cancer.
1999

Future prospects in prostate cancer.
1999

High intensity focused ultrasound in benign prostatic hyperplasia.
1999

Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent.
1998

Changes in regional renal blood flow after unilateral nephrectomy using the techniques of autoradiography and microautoradiography.
1998

Metabolic substrate utilization differs in ileal faecal and urinary reservoirs.
1998

Prostate cancer: how aware is the public?
1998

Sexual dysfunction associated with the management of prostate cancer.
1997

Determination of testicular function after torsion by DNA flow cytometry of serial fine-needle aspirates.
1996

Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument against.
1995

Cultured human sweat gland epithelia: isolation of glands using neutral red.
1994

Renal haemodynamics and prostaglandin synthesis in partial unilateral ureteric obstruction.
1994

Transurethral microwave thermotherapy versus transurethral catheter therapy for benign prostatic hyperplasia.
1993

Pancreatic atrophy: a new model using serial intra-peritoneal injections of L-arginine.
1993

The effect of stones on renal and ureteric physiology.
1992

Morphological changes and alterations in regional intrarenal blood flow induced by graded renal ischemia.
1992

The relationship between a nutritional index and acute physiology score in critical illness.
1991

The role of 3 hour distal oesophageal pH monitoring in gastro-oesophageal reflux.
1990

Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis.
1990

Minimally invasive surgery.
1990

The effect of caerulein induced pancreatitis on the hepatic microvasculature.
1989

Diurnal insulin and glucose profiles following transplantation of fresh and cryopreserved canine pancreatic islets.

These arethe11 unique sources for John M Fitzpatrick's 129 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 1
Ireland -> Dublin City University -> PubMed 1
Ireland -> National College Ireland 1
Ireland -> Royal College of Surgeons in Ireland 2
Ireland -> Royal College of Surgeons in Ireland -> PubMed 1
Ireland -> TU Dublin (Tallaght Campus) 1
Ireland -> TU Dublin (Tallaght Campus) -> PubMed 1
Ireland -> Trinity College Dublin 3
Ireland -> Trinity College Dublin -> PubMed 2
Ireland -> University College Dublin 121
Ireland -> University College Dublin -> PubMed 121

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.